Dynamic Antibody Response: a Biomarker for COVID-19

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• COVID-19 is a significant global health threat, representing the third human coronavirus outbreak of the 21st century.
• Host immune status critically influences COVID-19 severity and outcomes.
• Antibody responses are key indicators of antiviral defense, with delayed responses potentially impairing viral clearance.

Purpose of the Study:

• To synthesize literature on antibody responses in patients with Severe Acute Respiratory Syndrome (SARS) and COVID-19.
• To explore the potential of antibody dynamics for COVID-19 screening and prognosis.
• To review therapeutic applications of antibodies in COVID-19 management.

Main Methods:

• Rapid literature synthesis.
• Investigation of antibody responses in SARS and COVID-19 patient cohorts.

Main Results:

• Antibody responses in COVID-19 patients show potential for dynamic screening and prognostic applications.
• Neutralizing antibodies from recovered patients and cytokine-targeting monoclonal antibodies offer therapeutic avenues.
• Lessons learned from SARS inform understanding of COVID-19 antibody dynamics.

Conclusions:

• Antibody response dynamics are vital for assessing COVID-19 treatment effectiveness.
• Evaluating immunotherapy and vaccination efficacy may benefit from antibody response monitoring.
• Further research is needed on antibody extraction from animal models and the impact of factors like race, nutrition, and viral mutations on antibody responses.